Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Retinitis Pigmentosa

• Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
• Promising ROd-cone DYstrophy Gene therapY
• Oral N-acetylcysteine for Retinitis Pigmentosa
• Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa
• A Study in Subjects With Retinitis Pigmentosa
• A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of Small Molecule KIO-301 Administered Intravitreally to Patient s With Retinitis Pigmentosa (ABACUS)
• The Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Advanced Vision Loss (Sirius)
• An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
• Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa
• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
• PDE6A Gene Therapy for Retinitis Pigmentosa
• Sildenafil for Treatment of Choroidal Ischemia
• Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
• BS01 in Patients With Retinitis Pigmentosa
• A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
• Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)
• Minocycline Treatment in Retinitis Pigmentosa
• FIGHT-RP 1 Extension Study
• Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
• The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients
• The FIGHT-RP1 Study
• Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
• Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
• Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema
• RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa
• Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
• Safety and Tolerability of hRPC in Retinitis Pigmentosa
• Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
• Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa
• A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)
• Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
• Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)
• Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
• Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)
• Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
• Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01)
• Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
• Trial of Oral Valproic Acid for Retinitis Pigmentosa
• Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations
• An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa
• A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
• A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
• A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
• Autoimmunity in Retinitis Pigmentosa
• Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
• DHA and X-Linked Retinitis Pigmentosa
• Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa
• Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye
• Effects of Lutein in Retinitis Pigmentosa
• Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
• Randomized Trial for Retinitis Pigmentosa
• Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa